News

The next generation Watchman device is designed to better seal off complex LAA anatomy to prevent strokes in atrial fibrillation patients. It uses an optimized architecture to fill gaps and adapt to the unique characteristics of each patient's appendage, which come in a wide variety of shapes and sizes.
Next generation Watchman enters trial in 2026 as LAAO volume grows

The next generation Watchman device is designed to better seal off complex LAA anatomy in a variety of LAA shapes and sizes.

Thumbnail
ACC and AHA outline calculation of cost-effectiveness in clinical practice guidelines

Healthcare's cost-conscious environment prompted the ACC and AHA to develop a statement on the value methodology to be used when creating clinical practice guidelines.

The Artero peripheral electric IVL (E-IVL) system is about to enter its US FDA IDE trial.
FastWave lines up principal investigators for pivotal intravascular lithotripsy trial

"The key question isn't just whether a device works, but whether it makes procedures more efficient and provides physicians with a more predictable tool for treating patients with complex arterial disease," explained co-principal investigator Venita Chandra, MD, clinical professor of surgery at Stanford Health Care.

Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC, director of prevention, associate director, Barbra Streisand Women's Heart Center, Cedars-Sinai, and past president of the American Society for Preventive Cardiology (ASPC), was co-chair on a new joint scientific statement from the Heart Failure Society of America, and the ASPC on the need to boost prevention efforts for heart failure. She explains the new scientific statement that calls for greater prevention efforts in heart failure.
Putting more emphasis on prevention in heart failure care

Martha Gulati, MD, co-chair on a new joint scientific statement from the Heart Failure Society of America and the American Society for Preventive Cardiology, discusses the dire need she sees to boost prevention efforts for heart failure.

 

SCAI outlines broken Medicaid reimbursement model for congenital heart disease

SCAI says many children and adults living with congenital heart disease are being left behind by a payment system that does not adequately value their care.

mammogram mammography breast cancer
AI turns mammograms into CVD risk assessments—no outside data required

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

Vulnerable, but treatable: Semaglutide reduces symptoms in high-risk heart failure patients

Yes, even frail HFpEF patients see significant benefits when treated with semaglutide. Researchers believe these new data may help ease the minds of cardiologists everywhere.

Evinacumab-dgnb is sold by Regeneron under the brand name Evkeeza
FDA approves treatment of rare genetic disorder in children as young as 1 year old

Evinacumab-dgnb, sold by Regeneron under the brand name Evkeeza, can now be used to treat homozygous familial hypercholesterolemia in much younger patients.

Medtronic Evolut FX+ TAVR
World’s most populous country gains access to Medtronic’s newest TAVR valve

Medtronic developed the self-expanding Evolut FX+ TAVR system with improved coronary access in mind. The FDA-approved device has now officially launched in India. 

Joan Michaels, RN, director of the American College of Cardiology (ACC) National Cardiovascular Data Registry (NCDR) Transcatheter Valve Therapies (TVT) and IMPACT congenital heart registries, said the addition of the ambulatory surgical center (ASC) registry comes at a time when hospitals are expanding structural heart programs and ASC's will likely play a growing role to help free up more hospital cath labs for the more complex cases.
New registry helps hospitals expand outpatient services for heart patients

The initiation of the ACC Ambulatory Surgical Center Registry comes at a time when hospitals are expanding their structural heart programs. The registry is providing valuable details about which patients should stay at the hospital and which can be treated in an outpatient setting.

blood pressure hypertension cuff
FDA highlights risks of evaluating blood pressure with unauthorized medical devices

The agency emphasized that many over-the-counter technologies marketed for this purpose have not been properly evaluated. 

MGMA's Anders Gilberg says Congress needs to act soon to preserve access to telemedicine programs.
MGMA: Congress needs to act soon to preserve access to telemedicine programs

Congress needs to act soon to extend telemedicine services that were greatly expanded under COVID provisions, or they will expire by October. Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains concerns raised by doctors and lawmakers.

 

Around the web

Radiology Business
4D MRI techniques could help advance the development of artificial hearts

Researchers recently used advanced 4D flow MRI to track blood in a pulsating artificial heart, revealing dynamics that closely mirror those of a healthy human organ.

Health Exec
MGMA: Congress needs to act soon to preserve access to telemedicine programs

Congress needs to act soon to extend telemedicine services that were greatly expanded under COVID provisions, or they will expire by October. Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains concerns raised by doctors and lawmakers.

 

Health Exec
MGMA: Ending ACA subsidies could strain health system, leave millions uninsured

Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains the political and patient care issues involved with ending Affordable Care Act subsidies.